A Phase 2 Study of Fludarabine and Intermediate-dose Total Body Irradiation (800 cGy) Followed by Post-transplant Cyclophosphamide in Patients Aged 18 to 65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies

16593STUDY00009753-FLU-TBI-800OpenA Phase 2 Study of Fludarabine and Intermediate-dose Total Body Irradiation (800 cGy) Followed by Post-transplant Cyclophosphamide in Patients Aged 18 to 65 Undergoing Allogeneic Stem Cell Transplant for Hematologic MalignanciesPRO2025-0254NCT07214688InstitutionalAdultTreatmentIILeukemia, other; Lymphoid Leukemia; Multiple Myeloma; Myeloid and Monocytic LeukemiaKanakry, JenniferLombardi Comprehensive Cancer Center : Courtney BrownBone Marrow Transplant; Leukemia; Lymphoma; Multiple MyelomaOncology GroupLombardi Comprehensive Cancer Center (LCCC)17339Courtney BrownCourtney Browncb1974@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>